Unequal global access to inflammatory bowel disease (IBD) therapies creates profound health inequities. The increasing prevalence of IBD in Western countries, driven by high incidence rates and low ...

Even if it's not a huge purchase, we think it was good to see that Frederick DiSanto, the Independent Director of ...